PMID: 16524536Mar 10, 2006Paper

Modern epidemiology, prophylaxis, and diagnosis and therapy for infective endocarditis

Current Cardiology Reports
Lisa G Winston, Ann Bolger

Abstract

Infective endocarditis (IE) is a rare disease. Although its incidence and bacteriology have remained relatively stable in outpatient populations without injection drug use, health care-associated infections, particularly with staphylococcus, are becoming more common. Large-scale prospective clinical trials are unavailable to guide strategies for preventing IE, timing surgical intervention, and avoiding complications. We continue to rely on new data from smaller series and large observational databases to track these changes and improve care of patients. At the present time, there are several controversies regarding best practices in IE. In this review, we address the following questions: What is the future of recommendations for antibiotic prophylaxis against IE? How should we best use echocardiography in diagnosis, management and follow up of IE patients? What are the most appropriate antibiotic regimens for different patients in the face of shifting microbiology and demographics? Lastly, how should patients be selected for early surgery to avoid the complications of these infections?

References

Jan 1, 1977·Medicine·E D Everett, J V Hirschmann
Sep 1, 1991·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·S RohmannJ Meyer
Nov 1, 1991·Journal of the American College of Cardiology·A J SanfilippoA E Weyman
Apr 15, 1991·Annals of Internal Medicine·J M SteckelbergW R Wilson
Jan 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M L Fernández-GuerreroM de Górgolas
Jan 1, 1997·Annual Review of Medicine·M DasW R Wilson
Sep 24, 1999·The American Journal of Medicine·P A HeidenreichD K Owens
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A Frontera, J D Gradon
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S LiG R Corey
Mar 10, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·T KimA E Simor
Mar 27, 2001·Journal of the American College of Cardiology·G Di SalvoR Luccioni
Jan 17, 2002·The New England Journal of Medicine·E Mylonakis, S B Calderwood
May 29, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter B LockhartLarry J Strausbaugh
Jun 18, 2002·Heart·R O M NetzerC Seiler
Jul 3, 2002·Infectious Disease Clinics of North America·Michael L Towns, L Barth Reller
Apr 17, 2003·JAMA : the Journal of the American Medical Association·Rodrigo HasbunVincent J Quagliarello
Sep 6, 2003·Journal of the American College of Cardiology·Kwan-Leung ChanUNKNOWN Investigators of the Multicenter Aspirin Study in Infective Endocarditis
Dec 25, 2003·JAMA : the Journal of the American Medical Association·Holenarasipur R VikramVincent J Quagliarello
Jan 9, 2004·Infectious Disease Clinics of North America·John Turnidge
Jan 17, 2004·Lancet·Philippe Moreillon, Yok-Ai Que
Feb 24, 2005·Annals of Emergency Medicine·Bradley W FrazeeFrancoise Perdreau-Remington
Mar 5, 2005·The American Journal of Medicine·Fadi El-AhdabVance G Fowler
Apr 9, 2005·The New England Journal of Medicine·Scott K FridkinUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Apr 9, 2005·The New England Journal of Medicine·Loren G MillerBrad Spellberg
Apr 20, 2005·Journal of the American College of Cardiology·Robert O BonowPamela S Douglas
Jun 21, 2005·Emerging Infectious Diseases·Matthew J KuehnertDaniel B Jernigan
Jun 24, 2005·JAMA : the Journal of the American Medical Association·Vance G FowlerUNKNOWN ICE Investigators
Jun 24, 2005·JAMA : the Journal of the American Medical Association·Imad M TleyjehLarry M Baddour
Oct 7, 2005·Journal of Clinical Microbiology·D RaoultG Habib

❮ Previous
Next ❯

Citations

Jan 1, 2012·Journal of Community Hospital Internal Medicine Perspectives·Yan JiDawn Kershner
Jan 16, 2009·International Journal of Cardiology·Tsung O Cheng
May 16, 2014·Therapeutic Advances in Cardiovascular Disease·Cevdet FuratMustafa Yilmaz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Hannah L F CooperSamuel R Friedman
Current Problems in Cardiology
Thomas M BashoreVance Fowler
Lancet
Philippe Moreillon, Yok-Ai Que
JAMA : the Journal of the American Medical Association
A S DajaniStanford T Shulman
© 2021 Meta ULC. All rights reserved